Literature DB >> 9162875

Tumor necrosis factor-alpha (TNF-alpha)-induced optic neuropathy in rabbits.

M C Madigan1, A A Sadun, N S Rao, P U Dugel, W N Tenhula, P S Gill.   

Abstract

Both in vitro and in vivo studies have implicated a role for tumor necrosis factor-alpha (TNF alpha) in various demyelinating diseases, including HIV-related encephalopathy. To investigate whether intravitreal TNF alpha can induce optic nerve axonal damage in a rabbit eye model, fifteen rabbit eyes were initially injected with TNF alpha (final concentrations: 2U, 20U, and 200U respectively) and studied at varying time intervals for up to 24 weeks post-injection, using light and electron microscopy. Control optic nerves (no injection or diluent injection only) had normal myelinated axons and glia; the myelinated regions, neural retina, retinal glia and vasculature of control retinas were normal. In TNF alpha-exposed optic nerves, intact, degenerating and demyelinated axons were interspersed. Astrogliosis was present, particularly from 8 weeks p.i. and was noted up to 24 weeks. Oligodendrocytes were not severely affected in TNF alpha-exposed optic nerves, and activated macrophages or microglia were not obvious. Axonal degeneration was visible among the more superficial myelinated fibers in TNF alpha-exposed retinas however the neural retina glia were unaffected. These observations suggest that the axonal degeneration induced in TNF alpha-exposed rabbit optic nerves over a 24 week period was most likely related to direct effects of TNF alpha on optic nerve axons, and not primarily due to anterograde degeneration from retinal lesions. In-so-far as neurological pathology in general, and optic nerve degeneration in particular, has been described in AIDS, and TNF alpha levels may be elevated in this disease, it is of great clinical significance that TNF alpha has the capacity to mediate neuronal or axonal injury. If so, strategies to block or inhibit TNF alpha can be pursued for treatment for the neurological symptoms of AIDS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9162875     DOI: 10.1080/01616412.1996.11740399

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  20 in total

1.  Preservation of retina ganglion cell function by morphine in a chronic ocular-hypertensive rat model.

Authors:  Shahid Husain; Yasir Abdul; Craig E Crosson
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-28       Impact factor: 4.799

2.  Effect of host genetics on incidence of HIV neuroretinal disorder in patients with AIDS.

Authors:  Efe Sezgin; Sher L Hendrickson; Douglas A Jabs; Mark L Van Natta; Richard A Lewis; Jennifer L Troyer; Stephen J O'Brien
Journal:  J Acquir Immune Defic Syndr       Date:  2010-08       Impact factor: 3.731

3.  HIV-1 Tat-mediated neurotoxicity in retinal cells.

Authors:  Nivedita Chatterjee; Shannon Callen; Gail M Seigel; Shilpa J Buch
Journal:  J Neuroimmune Pharmacol       Date:  2011-01-28       Impact factor: 4.147

4.  Neuro-ophthalmological disorders in HIV infected subjects with neurological manifestations.

Authors:  J-C Mwanza; L K Nyamabo; T Tylleskär; G T Plant
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

5.  Opioid receptor activation: suppression of ischemia/reperfusion-induced production of TNF-α in the retina.

Authors:  Shahid Husain; Gregory I Liou; Craig E Crosson
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-20       Impact factor: 4.799

6.  Peroxiredoxin 6 delivery attenuates TNF-alpha-and glutamate-induced retinal ganglion cell death by limiting ROS levels and maintaining Ca2+ homeostasis.

Authors:  Nigar Fatma; E Kubo; M Sen; N Agarwal; W B Thoreson; C B Camras; D P Singh
Journal:  Brain Res       Date:  2008-07-29       Impact factor: 3.252

7.  Peripapillary retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in adult-onset familial Mediterranean fever.

Authors:  Sait Alim; Mehmet Esen; Ayşe Kevser Demir; Selim Demir; Hüseyin Ortak; Alper Güneş; Tufan Alatli; Helin Deniz Demir
Journal:  Int Ophthalmol       Date:  2017-01-21       Impact factor: 2.031

Review 8.  Diabetic retinopathy: new therapeutic perspectives based on pathogenic mechanisms.

Authors:  C Hernández; A Simó-Servat; P Bogdanov; R Simó
Journal:  J Endocrinol Invest       Date:  2017-03-29       Impact factor: 4.256

Review 9.  BAX to basics: How the BCL2 gene family controls the death of retinal ganglion cells.

Authors:  Margaret E Maes; Cassandra L Schlamp; Robert W Nickells
Journal:  Prog Retin Eye Res       Date:  2017-01-04       Impact factor: 21.198

10.  Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells.

Authors:  G Tezel; M B Wax
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.